Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-12T19:53:19.309Z Has data issue: false hasContentIssue false
  • English
  • Français

Shifting depression1

Published online by Cambridge University Press:  09 July 2009

I. C. Campbell ,
K. Marsden  and
J. F. Powell
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 24 , Issue 2 , May 1994 , pp. 271 - 273
Copyright
Copyright © Cambridge University Press 1994

References

Berridge, M. J. & Irvine, R. F. (1989). Inositol phosphates and cell signalling. Nature 341, 197–205.CrossRefGoogle ScholarPubMed
Brunello, N., Riva, M., Volterra, A. & Racagni, G. (1986). Biochemical changes in rat brain after acute and chronic administration of fluvoxamine, a selective 5HT uptake blocker: comparison with desmethylimipramine. Advances in Pharmacotherapy 2, 189–196 (Karger: Basel).Google Scholar
Campbell, I. C., McWilliam, J. R. & Adamson, P. (1987). Central adrenergic receptors. Journal of Psychopharmacology 2, 55–66.CrossRefGoogle Scholar
Cole, A. J., Saffen, D. W., Baraban, J. M. & Worley, P. F. (1989). Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340, 474–476.CrossRefGoogle ScholarPubMed
Coppen, A. (1967). The biochemistry of affective disorders. British Journal of Psychiatry 113, 1237–1264.CrossRefGoogle ScholarPubMed
Dechant, K. L. & Clissold, S. P. (1991). Paroxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs 41, 223–253.CrossRefGoogle ScholarPubMed
Hadcock, J. R. & Malbon, C. C. (1991). Regulating of receptor expression by agonists: transcriptional and post-transcriptional controls. Trends in Neurological Sciences, 14, 242–248.Google ScholarPubMed
Kitayama, I., Janson, A. M., Cintra, A., Fuxe, K., Agnati, L. F., Ogren, S.-O., Harfstrand, A., Eneroth, P. & Gustafsson, J.-A. (1988). Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Journal of Neural Transmission 73, 191–203.CrossRefGoogle ScholarPubMed
Kuhn, R. (1958). The treatment of depressive states with G22355 (imipramine hydrochloride). American Journal of Psychiatry 115, 459–464.CrossRefGoogle Scholar
Kupfer, D. J. & Frank, E. (1992). Minimum length of treatment for recovery. In Long-Term Treatment of Depression (ed. Montgomery, S. and Rouillon, F.), pp. 33–52. John Wiley: Chichester.Google Scholar
Leang, P. & Pardee, A. B. (1992). Differential display of enkaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.CrossRefGoogle Scholar
Lee, A. S. & Murray, R. M. (1988). The long-term outcome of Maudsley depressives. British Journal of Psychiatry 153, 741–751.CrossRefGoogle ScholarPubMed
Montgomery, S. & Montgomery, D. B. (1992). Prophylactic treatment in recurrent unipolar depression. In Long-Term Treatment of Depression (ed. Montgomery, S. and Rouillon, F.), pp. 53–79. John Wiley: Chichester.Google Scholar
Morgan, J. I. & Curran, T. (1991). Proto-oncogene transcription factors and epilepsy. Trends in Pharmacological Sciences, 12, 343–349.CrossRefGoogle ScholarPubMed
Palazzo, M. J. & Meyerowitz, E. M. (1987). A family of lambda phage cDNA cloning vector, lambda SWAJ, allowing the amplification of RNA sequences. Gene 52, 197–202.CrossRefGoogle Scholar
Peroutka, S. J. & Schmidt, A. W. (1991). An overview of 5-hydroxytryptamine receptor families. In 5-Hydroxytryptamine in Psychiatry. A Spectrum of Ideas (ed. Sandier, M., Coppen, A. and Harnett, S.) pp. 3–23. Oxford University Press: Oxford.Google Scholar
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders. American Journal of Psychiatry 122, 509–522.CrossRefGoogle ScholarPubMed
Swerdlow, N. R. & Koob, G. S. (1987). Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of corticostriato- pallido- thalamic function. Behavior and Brain Science 10, 197–245.CrossRefGoogle Scholar
Timblin, C., Battey, J. & Kuehl, W. M. (1990). Application for PCR technology to subtractive cDNA cloning: identification of genes expressed specifically in murine plasmocytoma cells. Nucleic Acid Research 18, 1587–1593.CrossRefGoogle Scholar
White, T. J., Arnheim, N. & Erlich, H. A. (1989). The polymerase chain reaction. Trends in Genetics 5, 185–189.CrossRefGoogle ScholarPubMed
Wisden, W., Errington, M. L., Williams, S., Dunnett, S. B., Waters, C., Hitchcock, D., Evans, G., Bliss, T. V. P. & Hunt, S. P. (1990). Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron 4, 603–614.CrossRefGoogle ScholarPubMed